MedTrace Logo

Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection

NCT00195026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2008-03-18

No results posted yet for this study

Summary

This protocol will evaluate a new non-invasive infrared imaging system as an adjunctive tool for breast cancer detection that has been approved by the FDA. The technology and device have been developed by Infrared Sciences Corp. and has undergone more than 3 years of testing prior. The subject device's utility will be investigated with regard to its sensitivity toward breast cancer, however it records temperature data and other physiological parameters of the breast, and compares them to a database of patients with known breast health.

Conditions

Interventions

DEVICE

Infrared Breast Scan

Patients already scheduled for breast biopsies will receive an additional infrared scan

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Michael Osborne, MD · NY Presbyterian Hospital Weill Cornell Breast Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00195026 on ClinicalTrials.gov